Through CRISPR-Cas9 screening and in vivo and in vitro experiments, the study also revealed the synthetic lethal interaction between FGFR3 and FGFR4 in FGF19-positive HCC. This evidence concerns the gene FGFR3 and hepatocellular carcinoma.